Specialist Updates 
Endocrinology

Do diabetes patients respond effectively to SARS-CoV-2?

Italian research suggests they do, but hyperglycaemia is still strongly associated with worse outcomes
Clare Pain
0
19 October 2020
Save
ClosePlease login
Coronavirus under antibody attack

Patients with type 2 diabetes mount an effective antibody response to the SARS-CoV-2 virus, Italian doctors report.

Their study also confirms previous research that hyperglycaemia correlates with worse outcomes for patients with COVID-19 pneumonia — with a dose-dependent effect.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .